Old Web
English
Sign In
Acemap
>
Paper
>
A50 iodogen labelling method preserves immunoreactivity of high specific activity 131I-labelled rituximab for clinical RIT
A50 iodogen labelling method preserves immunoreactivity of high specific activity 131I-labelled rituximab for clinical RIT
2006
Yong Du
M. Bayne
Maureen A. Zivanovic
Peter Johnson
Tim Illidge
Keywords:
Pathology
Labelling
Rituximab
Specific activity
Medicine
high specific activity
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]